CEP290 p.Arg1237fs
c.3708dup · rs758991387 · VCV1071036
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Consequence | frameshift | predicted loss-of-function |
|---|---|---|
| NMD | predicted | premature termination codon in exon 31 of 54 |
| Splicing | ||
| SpliceAI | — | not assessed · substitutions only |
| Constraint at this position | ||
| Conservation | phyloP 9.9 | phastCons 1 |
| Overall | ||
| CADD | 34.0 | PHRED · no single calibrated threshold — expert panels disagree |
Predicted loss-of-function is descriptive, not an applied PVS1 code.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,460 |
| South Asiangrpmax | 0.0011% | 91,080 |
| European (non-Finnish) | 0.000848% | 117,988 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CEP290
- Protein
- p.Arg1237fs
- Coding
- c.3708dup
- MANE Select
- NM_025114
- dbSNP
- rs758991387
- Type
- Duplication
- Location
- chr12:88089352 (GRCh38)
- Gene constraint
- LOEUF 1.094 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 60.90
- Residue 1237
- a UniProt-annotated variant site (in lca10; also found in a patient with night blindness and hearing loss); a UniProt-annotated variant site (in lca10); a UniProt-annotated variant site (in)
Disease context
CEP290-related disorder — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: Joubert syndrome 5Meckel syndrome, type 4Leber congenital amaurosis 10Bardet-Biedl syndrome 14Senior-Loken syndromeJoubert syndromeMeckel syndromeLeber congenital amaurosisnephronophthisisCEP290-related ciliopathy
Similar variants
- CEP290 p.Arg1237Cys Uncertain significance ★★ ⚠ same residue
- CEP290 p.Arg1237Leu Uncertain significance ★★ ⚠ same residue
- CEP290 p.Arg1237His Benign/Likely benign ★★ same residue
- CEP290 p.Asn1775fs Pathogenic ★★★ same condition
- CEP290 p.Asn85fs Likely pathogenic ★★★ same condition
- CEP290 p.Asp450fs Likely pathogenic ★★★ same condition
- CEP290 p.Leu1155fs Likely pathogenic ★★★ same condition
- CEP290 p.Lys1042Ter Pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cep290-p-arg1237fs (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown